Quantcast
Last updated on April 23, 2014 at 13:11 EDT

Latest NewCardio Inc. Stories

2012-01-11 06:00:00

PRINCETON, N.J., Jan. 11, 2012 /PRNewswire/ -- NewCardio, Inc., (OTC BB: NWCI) a cardiovascular diagnostic solutions developer, announced today that a biotechnology pharmaceutical company, which is focused on discovering and developing small molecule therapeutics for disorders of the central nervous system (CNS), has selected QTinno®, NewCardio's automated cardiac safety solution, for an upcoming Thorough QT trial. Fully automated ECG analysis, empowered by QTinno, will be delivered by...

2012-01-10 15:01:00

PRINCETON, N.J., Jan. 10, 2012 /PRNewswire/ -- NewCardio, Inc., (OTC BB: NWCI) a cardiovascular diagnostic solutions developer, announced changes to its Board of Directors and executive management. Effective January 1, 2012, Jess Jones, M.D. has been named Chief Executive Officer of the company, replacing Vincent W. Renz, Jr. Dr. Jones has been a member of the Company's Board of Directors since December 2008. From 2006 to December 2010 Dr. Jones worked with Vision Capital Advisors, LLC in...

2011-11-29 07:00:00

PRINCETON, N.J., Nov. 29, 2011 /PRNewswire/ -- NewCardio, Inc., (OTC BB: NWCI) a cardiovascular diagnostic solutions developer, announced today that a top 3 Clinical Research Organization (CRO) will utilize QTinno®, automated cardiac safety solution, to support a Phase I drug safety study for a biopharmaceutical sponsor. Fully automated ECG analysis, empowered by QTinno, will be delivered at the CRO's clinical pharmacology research unit under the terms...

2011-11-15 06:00:00

PRINCETON, N.J., Nov. 15, 2011 /PRNewswire/ -- NewCardio, Inc., (OTC BB: NWCI) a cardiac diagnostic technology provider, today announced financial results for the third quarter ended September 30, 2011. More details on the financial results are available in the Company's Quarterly Report on Form 10-Q, filed yesterday with the Securities and Exchange Commission. Highlights QTinno® was selected by a top 5 global pharmaceutical company for an upcoming Phase I drug safety...

2011-11-09 07:00:00

SANTA CLARA, Calif., Nov. 9, 2011 /PRNewswire/ -- NewCardio, Inc., (OTC BB: NWCI) a cardiovascular diagnostic solutions developer, announced today that its strategic partner, Clinilabs, will utilize QTinno®, NewCardio's automated cardiac safety solution, to conduct a Phase I trial of an investigational new drug under development for a central nervous system (CNS) indication. The assessment of cardiac safety will be one important aspect of the trial. Clinilabs, located...

2011-11-07 07:00:00

SANTA CLARA, Calif., Nov. 7, 2011 /PRNewswire/ -- NewCardio, Inc., (OTC BB: NWCI) a cardiovascular diagnostic solutions developer, announced today that a top 5 global pharmaceutical company has selected QTinno®, their automated cardiac safety solution, for an upcoming Phase I drug safety study. Fully automated ECG analysis, empowered by QTinno, will be delivered by the ECG core lab of a top 3 Clinical Research Organization (CRO) under the terms of an existing Master...

2011-08-15 15:01:00

SANTA CLARA, Calif., Aug. 15, 2011 /PRNewswire/ -- NewCardio, Inc., (OTC BB: NWCI) a cardiac diagnostic technology provider, today announced financial results for the second quarter ended June 30, 2011. More details on the financial results are available in the Company's Quarterly Report on Form 10-Q, filed today with the Securities and Exchange Commission. Highlights QTinno® was selected by a top 5 global pharmaceutical company for two Phase I drug safety studies, both...

2011-06-23 07:00:00

SANTA CLARA, Calif., June 23, 2011 /PRNewswire/ -- NewCardio, Inc., (OTC BB: NWCI) a cardiac diagnostic technology provider, announced today that Patrick Maguire, MD, PhD, member of the NewCardio board of directors since March of 2008 and a proven leader and a seasoned executive with experience in a variety of leadership roles with companies involved in medical devices and pharmaceuticals, has been elected Chairman of NewCardio's Board of Directors, effective immediately. Mark W. Kroll,...

2011-06-17 07:00:00

SANTA CLARA, Calif., June 17, 2011 /PRNewswire/ -- NewCardio, Inc., (OTC BB: NWCI) a cardiac diagnostic technology provider, announced today that Vincent Renz, Chief Executive Officer, is scheduled to present at the Wells Fargo Securities Healthcare Conference. The Conference is on June 22 and 23, 2011, at The InterContinental Boston. Mr. Renz' presentation is scheduled for 3:30 p.m. ET on Wednesday, June 22. Investors planning to attend the conference should contact their Wells Fargo...

2011-06-16 07:00:00

SANTA CLARA, Calif., June 16, 2011 /PRNewswire/ -- NewCardio, Inc., (OTC BB: NWCI) a cardiac diagnostic technology provider, announced today that two of its recent medical and technical submissions have been accepted for their presentations at the 33rd Annual International Conference of the IEEE Engineering in Medicine and Biology Society conference. The two papers: 'Wireless Monitoring of Reconstructed 12-Lead ECG in Atrial Fibrillation Patients Enables Differential Diagnosis of...